Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 474 publications
APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial.
Journal: JCO precision oncology
Published: August 21, 2026
Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer.
Journal: JAMA network open
Published: June 24, 2026
A Watershed Moment in the Perioperative Treatment of Prostate Cancer.
Journal: The New England journal of medicine
Published: June 01, 2026
An argument not to EMBARK on systemic therapy for biochemical recurrence of prostate cancer.
Journal: Translational andrology and urology
Published: May 07, 2026
Vobramitamab duocarmazine, an anti-B7-H3 antibody-drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion.
Journal: Cancer
Published: April 08, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 26, 2026
Steroidogenesis inhibitor opevesostat (MK-5684) for metastatic castration-resistant prostate cancer: OMAHA-003 and OMAHA-004 trial designs.
Journal: Future oncology (London, England)
Published: February 24, 2026
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing Testing.
Journal: JCO oncology practice
Published: February 19, 2026
Targeted proteomics for the detection of androgen receptor variants in preclinical models of castration-resistant prostate cancer.
Journal: Clinical proteomics
Published: February 12, 2026
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities Across Prostate Cancer Patient Groups.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 09, 2026
Last Updated: 09/26/2026